Fri, Sep 19, 2014, 9:59 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

mazmike147 1 post  |  Last Activity: Jul 7, 2014 8:43 AM Member since: Nov 22, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • mazmike147 by mazmike147 Jul 7, 2014 8:43 AM Flag

    Saw that RNA filed a shelf the day before a holiday (Not too sneaky)...for 150mm and I saw other reports that insiders will be offering an additional 240mm (Is that confirmed?). If so, that amounts to approx 50% dilution. Stock trading down to 11 pre-market which is off about 12% from last week close. So I get my facts right here, Glaxo abandons funding for company, they consistently reiterate the same news, drug does not have the same safety profile as SRPT and now insiders get paid off. It is all that is wrong with Wall Street. This is borderline criminal but as long as the file the proper disclosures, all is good. Company will be bankrupt in 12-24 months.

    Sentiment: Strong Buy

SRPT
21.78-0.75(-3.33%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.